10-Q/A: Range Impact Inc. Restates Q1 2024 Financials Due to Accounting Error and Material Weakness

Range Impact Inc. has restated its first quarter 2024 financial statements due to an improperly recorded expense and has identified a material weakness in its internal controls.

Summary

• Range Impact Inc. is filing an amendment to its original 10-Q report for the quarter ended March 31, 2024.
• The restatement is due to a $462,691 vendor invoice related to a subcontractor that was incorrectly posted in April 2024 instead of March 2024.
• This error resulted in understated expenses and overstated net income for the first quarter of 2024.
• The company has also identified a material weakness in its internal control over financial reporting.
• The company's disclosure controls and procedures were deemed ineffective at the time the original financial statements were issued.
• The restated financials show a net loss of $1,213,840 for the quarter, compared to a previously reported loss of $751,149.
• The company's revenue for the quarter was $3,909,893, and gross profit was $18,854.
• The company had total current assets of $7,388,656 and total current liabilities of $7,359,902, resulting in working capital of $28,754 as of March 31, 2024.
• The company operates six business segments: Range Reclaim, Range Minerals, Range Water, Range Security, Range Land, and Graphium Biosciences.

Sentiment

Score: 3

Explanation: The document reveals significant financial issues, including a restatement due to an accounting error, a material weakness in internal controls, and a substantial net loss. While the company has growth plans and operates in a relevant sector, the current financial state and control deficiencies raise concerns.

Positives

• The company's revenue increased by $895,006 compared to the same period last year, driven by new business in the Range Reclaim segment.
• The company is actively working to remediate the identified material weakness in internal controls.
• The company has a diverse range of operating segments focused on environmental and social impact.
• The company is exploring financing options to accelerate its growth strategy.

Negatives

• The company experienced a significant net loss of $1,213,840 for the quarter.
• The company identified a material weakness in its internal control over financial reporting.
• The company's disclosure controls and procedures were not effective at the time of the original filing.
• The company's gross profit was significantly impacted by increased depreciation on equipment acquired in August 2023.
• The company's working capital was only $28,754 as of March 31, 2024.
• The company is heavily reliant on a single customer, which accounted for 67% of total sales.

Risks

• The company's reliance on a single major customer poses a significant concentration risk.
• The identified material weakness in internal controls could lead to future financial misstatements.
• The company's ability to continue as a going concern depends on its ability to generate positive cash flow and secure additional financing.
• The company's drug development program is subject to extensive regulation and requires significant capital investment.
• The company faces competition from larger and better-capitalized businesses and investment funds.
• The company's estimates of cash necessary to fund its business may prove to be too low.

Future Outlook

The company expects its operating businesses to generate operating income and positive cash flow over the 12 months following March 31, 2024, and believes it has sufficient funds to operate its business over the next 12 months. The company is also exploring financing options to accelerate its growth strategy.

Management Comments

• The company strives to instill a corporate culture of honesty, integrity and respect while advancing its mission of doing well by doing good.
• The company believes that doing well and doing good are not mutually exclusive, and that an impact investing strategy can balance the environmental, social and economic needs of people and the planet while also generating attractive risk-adjusted financial returns for shareholders.

Industry Context

The company operates in the impact investing space, focusing on environmental and social solutions in economically disadvantaged regions, particularly Appalachia. The company's land reclamation and water restoration services are relevant given the large number of abandoned and idled mine sites in the region. The company's biochar and security services also align with the growing focus on sustainable practices and environmental protection.

Comparison to Industry Standards

• The company's reliance on a single customer for a large portion of its revenue is a risk that is not uncommon in the environmental services industry, but it is higher than the industry average.
• The company's net loss and negative gross profit margin for the quarter are below industry standards for companies of similar size and stage.
• The company's identification of a material weakness in internal controls is a significant concern and indicates a need for improvement in its financial reporting processes.
• The company's focus on impact investing and sustainable solutions aligns with current industry trends, but its financial performance needs to improve to be competitive.

Stakeholder Impact

• Shareholders will be negatively impacted by the restatement and the identified material weakness.
• Employees may be affected by the company's financial challenges and potential restructuring.
• Customers may be concerned about the company's ability to deliver services due to its financial situation.
• Creditors may be concerned about the company's ability to repay its debts.
• Suppliers may be concerned about the company's ability to pay for goods and services.

Next Steps

• The company will update its procedures regarding the review of expenses and accruals of expenses to the proper period.
• The company will continue to evaluate and improve its internal control over financial reporting.
• The company will explore financing options to accelerate its growth strategy.
• The company will continue to develop its biochar-based passive treatment system for mine site discharges.
• The company will expand its security service business to additional mine sites.
• The company will continue to review mine sites for acquisition, reclamation, and repurposing.
• The company will advance its leading drug candidate, VBX-100, through Phase II clinical trials.

Key Dates

Keywords

restatement, material weakness, internal control, financial reporting, land reclamation, water restoration, environmental services, cannabinoid, drug development, impact investing, mine reclamation, biochar